In 2006, Novartis fully commited US$755 million in company citizenship initiatives world wide, specifically concentrating on increasing use of medicines within the producing earth by means of its Use of Medication projects, including donations of medicines to patients afflicted by leprosy, tuberculosis, and malaria; Glivec affected individual aid packages; and https://www.social-bookmarking.org/en/harnessing-cutting-edge-techniques-for-advanced-pharmaceutical-outcomes